Exane Derivatives
- SEC CIK
- 0001623883
- Latest filing
- Jul 12, 2022
ABT holding history
Abbott Laboratories in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2022 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −939−100.0% | Sold out | Holders |
| Q1 2022 | 939 | $111.1K | <0.1% | −769−45.0% | Reduced | Holders |
| Q4 2021 | 1,708 | $240.4K | 0.1% | +62+3.8% | Added | Holders |
| Q3 2021 | 1,646 | $194.4K | <0.1% | +1,392+548.0% | Added | Holders |
| Q2 2021 | 254 | $30.1K | <0.1% | +254 | New | Holders |